JAK2 and erythroleukemia: It was reported that several oncogenic tyrosine kinases phosphorylated LDHA at Y10 in various cancers, such as FGFR1 in lung cancer, BCR-Abl in chronic myelogenous leukemia, and JAK2 in human erythroleukemia [18].